Fan Qilin, Shang Fumei, Chen Chen, Zhou Hongxia, Fan Jun, Yang Ming, Nie Xiu, Liu Li, Cai Kailin, Liu Hongli
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Cancer Manag Res. 2021 Mar 19;13:2655-2667. doi: 10.2147/CMAR.S294936. eCollection 2021.
Intestinal microbiota play a critical role in the development of colorectal cancer. However, little is known about the structure and characteristics of gut microbial in colorectal cancer, especially in locally advanced rectal cancer after neoadjuvant chemoradiation therapy.
Here, we performed this study to evaluate microbial characteristics between pathologic complete response (pCR) (n=12) and non-pathological complete response (Non-pCR) (n=45) tumor tissues from patients with locally advanced rectal cancer after neoadjuvant chemoradiation therapy. In this study, 16S rRNA gene sequencing was used to detect the microbial diversity including Alpha diversity and Beta diversity. Moreover, we used PICRUSt from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database to predict the microbial metabolism functions.
There was significant statistical difference in PFS between pCR and Non-pCR group ( < 0.05). However, there was no significant difference in OS between pCR and Non-pCR group. The microbial compositions in the both groups were and and at the phylum level. The five most predominant genera in both pCR and Non-pCR tissue groups were and at the genus level. The key taxa identified in the pCR and Non-pCR tissues were and respectively. In addition, a series of human disease-related genes were also significantly different between pCR and Non-pCR group.
In summary, we demonstrated the characteristic differences in microbial communities between pCR tissues and Non-pCR tumor tissues from locally advanced rectal cancer patients after neoadjuvant chemoradiation therapy. Our results present new alterations in the microbiome in locally advanced rectal cancer after neoadjuvant chemoradiation therapy, suggesting that it will provide a new perspective for the precise treatment of neoadjuvant rectal cancer by targeting specific microbial species in the future.
肠道微生物群在结直肠癌的发生发展中起关键作用。然而,对于结直肠癌中肠道微生物的结构和特征,尤其是新辅助放化疗后局部晚期直肠癌的肠道微生物情况,人们了解甚少。
在此,我们开展本研究以评估新辅助放化疗后局部晚期直肠癌患者病理完全缓解(pCR)(n = 12)和非病理完全缓解(Non - pCR)(n = 45)肿瘤组织之间的微生物特征。在本研究中,采用16S rRNA基因测序检测微生物多样性,包括α多样性和β多样性。此外,我们使用京都基因与基因组百科全书(KEGG)数据库中的PICRUSt预测微生物代谢功能。
pCR组和Non - pCR组之间的无进展生存期(PFS)存在显著统计学差异(<0.05)。然而,pCR组和Non - pCR组之间的总生存期(OS)无显著差异。两组在门水平的微生物组成分别为 、 和 。pCR和Non - pCR组织组中五个最主要的属在属水平分别为 和 。在pCR和Non - pCR组织中鉴定出的关键分类群分别为 和 。此外,pCR组和Non - pCR组之间一系列与人类疾病相关的基因也存在显著差异。
总之,我们证明了新辅助放化疗后局部晚期直肠癌患者pCR组织和Non - pCR肿瘤组织之间微生物群落的特征差异。我们的结果呈现了新辅助放化疗后局部晚期直肠癌微生物组的新变化,表明未来通过靶向特定微生物物种将为新辅助直肠癌的精准治疗提供新的视角。